Volume 16, Number 12—December 2010
Serologic Evidence of Pandemic (H1N1) 2009 Infection in Dogs, Italy
Highlight and copy the desired format.
|EID||Dundon WG, De Benedictis P, Viale E, Capua I. Serologic Evidence of Pandemic (H1N1) 2009 Infection in Dogs, Italy. Emerg Infect Dis. 2010;16(12):2019-2021. https://dx.doi.org/10.3201/eid1612.100514|
|AMA||Dundon WG, De Benedictis P, Viale E, et al. Serologic Evidence of Pandemic (H1N1) 2009 Infection in Dogs, Italy. Emerging Infectious Diseases. 2010;16(12):2019-2021. doi:10.3201/eid1612.100514.|
|APA||Dundon, W. G., De Benedictis, P., Viale, E., & Capua, I. (2010). Serologic Evidence of Pandemic (H1N1) 2009 Infection in Dogs, Italy. Emerging Infectious Diseases, 16(12), 2019-2021. https://dx.doi.org/10.3201/eid1612.100514.|
To the Editor: Until recently, the general consensus has been that dogs are poorly susceptible to natural infection with influenza A viruses; however, since the recent upsurge of influenza A circulating subtypes H5N1 and H1N1 viruses, cases of natural infection in dogs have apparently increased. Thus, the role of these animals is being reconsidered in the transmission and spread of influenza viruses (1–3).
In April 2009, the most recent of the human influenza A pandemics, pandemic (H1N1) 2009, was detected in Mexico. The virus rapidly spread worldwide, within weeks of its first isolation. To date, pandemic (H1N1) 2009 has primarily infected humans, although transmission from infected humans to other animals, including pigs, turkeys, ferrets, cats, and dogs has been reported (4,5).
In Italy (population ≈58 million), the first human cases of pandemic (H1N1) 2009 were reported in May 2009; confirmed cases peaked during the second week of November 2009 (week 46) (6). As of May 9, 2010, Italy had recorded an estimated 5,582,000 cases of pandemic (H1N1) 2009. In Italy as well, the population has ≈7 million companion dogs and ≈7.5 million cats (7). Because of the close contact between persons and their companion animals, we initiated this serologic study to determine whether evidence of pandemic (H1N1) 2009 transmission could be found in companion animals in Italy.
We tested serum specimens from dogs (n = 964) and cats (n = 97), originally submitted to the Istituto Zooprofilattico Sperimentale delle Venezie in Legnaro, Italy, from October through December 2009 (weeks 41–53), for assessment of rabies vaccine efficacy. An average of 70 samples were tested per week; the highest number of samples (n = 106) was tested for week 51 and the lowest (n = 25) for week 53. Testing for antibody to influenza A nucleoprotein was performed by using a commercially available competitive ELISA (cELISA) (ID Screen Influenza A Antibody Competition Assay; ID Vet, Montpellier, France), according to the manufacturer’s instructions. Previous work from our laboratory has assigned a sensitivity of 93.98% and specificity of 98.71% to this cELISA for the testing of canine serum samples (8). In total, 29 serum specimens tested at a 1:10 dilution, all from dogs, were positive after a second confirmatory screening. None of the 97 feline serum samples were positive by cELISA.
The cELISA-positive serum specimens were then treated with receptor-destroying enzyme (RDE; Sigma-Aldrich, St. Louis, MO, USA) (1 part serum: 3 parts RDE) for 16 h at 37°C, followed by heat inactivation at 56°C for 30 min. We then tested the specimens by the hemagglutination inhibition (HI) test against the pandemic virus A/Verona/Italy/2810/2009 (H1N1), A/swine/Italy/711/2006 (H1N1), and H3N8 (A/canine/Florida/2004) by using 0.5% chicken erythrocytes and standard methods (9). Seven serum samples (nos. 4410, 4438, 4444, 4460, 4517, 4520, 4681) were positive by HI to A/Verona/Italy/2810/2009 (H1N1) with titers ranging from 16 to 256 (Table), but not for the other viruses, although the samples with the higher titers of 256 (nos. 4460 and 4681) against A/Verona/Italy/2810/2009 also cross-reacted with antigen A/swine/Italy/711/2006 (H1N1) (titers 16 and 32, respectively).
The HI-positive serum specimens were later tested in a microneutralization assay with A/Verona/Italy/2810/2009 (H1N1). Suppression of virus antigen expression was assessed by an ELISA assay as endpoint by using a slight modification of a previously described procedure (10). As can be seen from the Table, all 7 serum specimens positive by HI for A/Verona/Italy/2810/09 inhibited infection of MDCK cells by the same virus at dilutions of 1:160 or higher, confirming the presence of anti-H1 antibodies.
To summarize, in this study, 1,061 serum specimens from companion dogs and cats collected during the circulation peak of pandemic (H1N1) 2009 in Italy were screened with 7 (0.7%) of the canine serum specimens showing evidence of exposure to the virus. Notably, the positive samples were collected during the period (weeks 43–45) that almost coincided with the reported peak for human cases of pandemic (H1N1) 2009 in Italy (week 46). Totals of 69, 77, and 56 samples were collected during weeks 43, 44, and 45, respectively, which indicates that the sample group had no bias.
The data thus suggest that transmission occurred, most probably by aerosol or close contact, between pandemic (H1N1) 2009–infected owners and their pets during this peak period of mid-November 2009. How long these animals were infected, whether the infection had clinical manifestations, and whether the dogs were capable of transmitting the virus to other hosts are all questions that remain unanswered. However, on the basis of the low number of positive specimens identified in this study, it would be unrealistic to suggest that dogs are particularly susceptible to pandemic (H1N1) 2009. Nevertheless, as has been seen with infection of dogs with subtype H3N8, influenza A viruses are quite capable of evolving and becoming more host specific. This factor alone would justify the continued surveillance of influenza A viruses in domestic dogs.
We thank Giovanni Cattoli for critical reading of the manuscript.
This work was supported by the Italian Ministry of Health and the EU FLUTRAIN project.
- Capua I, Alexander DJ. Ecology, epidemiology and human health implications of avian influenza viruses: why do we need to share genetic data? Zoonoses Public Health. 2008;55:2–15.
- Crawford PC, Dubovi EJ, Castleman WL, Stephenson L, Gibbs EPJ, Chen L, Transmission of equine influenza virus to dogs. Science. 2005;310:482–5.
- Song D, Kang B, Lee K, Jung K, Ha G, Kang D, Transmission of avian influenza virus (H3N2) to dogs. Emerg Infect Dis. 2008;14:741–6.
- Sponseller BA, Strait E, Jergens A, Trijillo J, Harmon K, Koster L, Influenza A pandemic (H1N1) 2009 virus infection in domestic cat. Emerg Infect Dis. 2010;16:534–7.
- American Veterinary Medical Association. N.Y. dog infected with H1N1; study shows virus not in pork [cited 2010 Apr]. http//www.avma.org/onlnews/javma/feb10/100201e.asp
- Italian Ministry of Health. Nuova influenza [cited 2010 Aug]. http://www.nuovainfluenza.salute.gov.it/nuovainfluenza/nuovaInfluenza.jsp
- Italian Ministry of Health. Cani, gatti e… [cited 2010 Apr]. http://www.salute.gov.it/caniGatti/caniGatti.jsp
- De Benedictis P, Anderson TC, Perez A, Viale E, Veggiato C, Tiozzo Caenazzo S, A diagnostic algorithm for detection of antibodies to influenza A in dogs in Italy (2006–2008). J Vet Diagn Invest. 2010. In press.
- World Organisation for Animal Health. Manual of diagnostic tests and vaccines for terrestrial animals. 6th ed. Paris: The Organisation; 2008.
- Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, Lim W, Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol. 1999;37:937–43.
- Table. Anagraphic data and HI and MN titers of canine serum specimens against A/Verona/Italy/2810/2009 (H1N1), 2009
Please use the form below to submit correspondence to the authors or contact them at the following address:
William G. Dundon, OIE/FAO and National Reference Laboratory for Avian Influenza and Newcastle disease, Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell´Università 10, 35020 Legnaro (PD), Italy
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: August 28, 2011
- Page last updated: August 28, 2011
- Page last reviewed: August 28, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)